Dr. Havlichek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4650 S Hagadorn Rd
Ste 100
East Lansing, MI 48823Phone+1 517-353-4830Fax+1 517-355-2134
Education & Training
- Henry Ford Health/Henry Ford HospitalFellowship, Infectious Disease, 1984 - 1986
- Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 1981 - 1984
- University of Michigan Medical SchoolClass of 1981
Certifications & Licensure
- MI State Medical License 1983 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Urinary Bactericidal Activity of 4 Doses of Levofloxacin Against Fluoroquinolone-Resistant E. Coli Start of enrollment: 2006 Sep 01
Publications & Presentations
PubMed
- Regarding The Clinical and Economic Burden of Norovirus Gastroenteritis in the United StatesSteven Do, Daniel H. Havlichek
The Journal of Infectious Diseases. 2021-08-16 - 5 citationsLong-Acting Lipoglycopeptides for the Treatment of Bone and Joint Infections.Christopher C Cooper, Gary E. Stein, Subhashis Mitra, Ahmed Abubaker, Daniel H. Havlichek
Surgical Infections. 2021-04-09 - A Trial of Lopinavir-Ritonavir in Covid-19.Daniel Havlichek
The New England journal of medicine. 2020-05-06
Press Mentions
- FDA Approves Booster Shots for All Adults but Too Late to Stop Winter SurgeNovember 19th, 2021
- Lockdowns Could Slow Delta Variant Cases, but Health Experts Consider It Difficult OptionJuly 16th, 2021
- How Will Widespread Vaccinations Affect Concerts, Weddings and Other Large Gatherings?March 8th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: